Intrauterine Insemination in Women with Endometriosis

Although intrauterine inseminations (IUI) with or without superovulation have been widely used in treating endometriosis-related infertility, the available studies are limited by small sample size, experimental design, and heterogenous study populations. IUI is effective in improving fertility in women with stages I–II endometriosis compared with expectant management, and, in these patients, IUI preceded by controlled ovarian hyperstimulation results in higher pregnancy rates compared with IUI alone. IUI may be less efficacious in patients with stages III–IV compared with those with stages I–II, possibly because the anatomic distortion caused by endometriosis may impair fertility. Limited data are available on the role of hormonal suppression of endometriosis before IUI, and, therefore, it cannot be recommended because the potential improvement in pregnancy rates must be balanced with the adverse effects of treatment and the delay in the treatment. Access this chapter Tax calculation will be finalised at checkout Purchases are for personal use only Similar content being viewed by others

Yovich JL, Matson PL. The treatment of infertility by the high intrauterine insemination of husband's washed spermatozoa. Hum Reprod. 1988;3(8):939–43. Omland AK, et al. Artificial insemination by husband in unexplained infertility compared with infertility associated with peritoneal endometriosis. Hum Reprod. 1998;13(9):2602–5. Mansour G, et al. Stage of endometriosis does not affect intrauterine insemination outcome. Fertil Steril. 2008;90:S138–9. Fedele L, et al. Superovulation with human menopausal gonadotropins in the treatment of infertility associated with minimal or mild endometriosis: a controlled randomized study. Fertil Steril. 1992;58(1):28–31. Tummon IS, et al. Randomized controlled trial of superovulation and insemination for infertility associated with minimal or mild endometriosis. Fertil Steril. 1997;68(1):8–12. Nulsen JC, et al. A randomized and longitudinal study of human menopausal gonadotropin with intrauterine insemination in the treatment of infertility. Obstet Gynecol. 1993;82(5):780–6. Prado-Perez J, et al. The impact of endometriosis on the rate of pregnancy of patients submitted to intrauterine insemination. Fertil Steril. 2002;77:S51. Werbrouck E, et al. No difference in cycle pregnancy rate and in cumulative live-birth rate between women with surgically treated minimal to mild endometriosis and women with unexplained infertility after controlled ovarian hyperstimulation and intrauterine insemination. Fertil Steril. 2006;86(3):566–71. van der Houwen LE, et al. Efficacy and safety of intrauterine insemination in patients with moderate-to-severe endometriosis. Reprod Biomed Online. 2014;28(5):590–8. Keresztúri A, et al. Pregnancy rate after controlled ovarian Hyperstimulation and intrauterine insemination for the treatment of endometriosis following surgery. Biomed Res Int. 2015;2015:282301. Cai H, et al. Efficacy of intrauterine insemination in women with endometrioma-associated subfertility: analysis using propensity score matching. BMC Pregnancy Childbirth. 2022;22(1):12. Van Der Houwen LEE, et al. Pregnancy rates after intrauterine insemination in moderate to severe endometriosis: a systematic review and meta-analysis of observational studies. J Endometr Pelvic Pain Disorders. 2017;9(3):158–67. Rickes D, et al. Increased pregnancy rates after ultralong postoperative therapy with gonadotropin-releasing hormone analogs in patients with endometriosis. Fertil Steril. 2002;78(4):757–62. Kim CH, Cho YK, Mok JE. Simplified ultralong protocol of gonadotrophin-releasing hormone agonist for ovulation induction with intrauterine insemination in patients with endometriosis. Hum Reprod. 1996;11(2):398–402. Zhang K, et al. Effectiveness of gonadotrophin-releasing hormone agonist therapy to improve the outcomes of intrauterine insemination in patients suffering from stage I-II endometriosis. Ann Med. 2022;54(1):1330–8. D'Hooghe TM, et al. Is the endometriosis recurrence rate increased after ovarian hyperstimulation? Fertil Steril. 2006;86(2):283–90. Deaton JL, et al. A randomized, controlled trial of clomiphene citrate and intrauterine insemination in couples with unexplained infertility or surgically corrected endometriosis. Fertil Steril. 1990;54(6):1083–8. Becker CM, et al. ESHRE guideline: endometriosis. Hum Reprod Open. 2022;2022(2):hoac009. Nuojua-Huttunen S, et al. Intrauterine insemination treatment in subfertility: an analysis of factors affecting outcome. Hum Reprod. 1999;14(3):698–703. Goker EN, et al. Controlled ovarian hyperstimulation and intrauterine insemination for infertility associated with endometriosis: a retrospective analysis. Arch Gynecol Obstet. 2002;266(1):21–4. Lodhi S, et al. Gamete intra-fallopian transfer or intrauterine insemination after controlled ovarian hyperstimulation for treatment of infertility due to endometriosis. Gynecol Endocrinol. 2004;19(3):152–9. Author information Authors and Affiliations Corresponding author Editor information Editors and Affiliations Rights and permissions Copyright information © 2024 The Author(s), under exclusive license to Springer Nature Switzerland AG About this chapter Cite this chapter Ferrero, S., Leone Roberti Maggiore, U., Bernardini, L. (2024). Intrauterine Insemination in Women with Endometriosis. In: Ferrero, S. (eds) Endometriosis-related Infertility. Springer, Cham. https://doi.org/10.1007/978-3-031-50662-8_13 Download citation DOI: https://doi.org/10.1007/978-3-031-50662-8_13 Published: Publisher Name: Springer, Cham Print ISBN: 978-3-031-50661-1 Online ISBN: 978-3-031-50662-8 eBook Packages: MedicineMedicine (R0)